In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 27th, 2005 | 29 | Yes |
Popular Name: Ketanserin Ketanserin
Find On: PubMed — Wikipedia — Google
CAS Numbers: 74050-98-9 , 83846-83-7 , 83846-83-7, 74050-98-9(base) , [74050-98-9] , [83846-83-7]
(+)-3-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione
2,4(1H,3H)-Quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-
3-(2-(4-(4-Fluorobenzoyl)piperidin-1-yl)-ethyl)quinazoline-2,4(1H,3H)-dione
3-(2-(4-(4-Fluorobenzoyl)piperidin-1-yl)ethyl)quinazoline-2,4(1H,3H)-dione
3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione
3-(2-(4-(p-Fluorobenzoyl)piperidino)ethyl)-2,4-(1H,3H)-quinazolinedione
3-(2-{4-[(4-fluorophenyl)carbonyl]piperidin-1-yl}ethyl)quinazoline-2,4(1H,3H)-dione
3-[2-[4-(4-fluorobenzoyl)-1-piperidyl]ethyl]-1H-quinazoline-2,4-dione
3-[2-[4-(4-fluorobenzoyl)-1-piperidyl]ethyl]-1H-quinazoline-2,4-dione; Ketanserin
3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-1H-quinazoline-2,4-dione
3-{2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl}-2,4(1H,3H)-quinazolinedione
3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}quinazoline-2,4(1H,3H)-dione
74050-98-9; C07464; Ketanserin
74050-98-9; D02363; Ketanserin (USAN/INN)
83846-83-7; D08099; Ketanserin tartrate; Sufrexal (TN)
83846-83-7; Ketanserin tartrate hydrate; Prestwick_738
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.81 | 10.61 | -45.69 | 2 | 6 | 1 | 76 | 396.442 | 5 | ↓ |
Mid Mid (pH 6-8) | 3.27 | 8.76 | -44.34 | 1 | 6 | 0 | 79 | 395.434 | 5 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Target | 5-HT Receptor | Selleck Chemicals |
therap | 5HT2/5HT1C seritonin antagonist | MicroSource Spectrum |
Purity | 95% | Fluorochem |
Patent Database Links | EP1553091; EP1717226; EP1772452; EP1862181; EP1879027; US2002061879; US2002115655; US2002143007; US2004142904; US2005065161; US2005187222; US2007189977; US2007189978; US2007190023; US2007196323; US2007196452; US2007196453; US2007203119; US2007207222; US20 | ChEBI |
Therapy | Selective 5-HT2 serotonin receptor blocker | SMDC Pharmakon |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
5HT1A-1-E | Serotonin 1a (5-HT1a) Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 1933 | 0.28 | Binding ≤ 10μM |
5HT1B-1-E | Serotonin 1b (5-HT1b) Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1900 | 0.28 | Binding ≤ 10μM |
5HT1D-1-E | Serotonin 1d (5-HT1d) Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 270 | 0.32 | Binding ≤ 10μM |
5HT2A-1-E | Serotonin 2a (5-HT2a) Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 3 | 0.41 | Binding ≤ 10μM |
5HT2A-1-E | Serotonin 2a (5-HT2a) Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 3 | 0.41 | Binding ≤ 10μM |
5HT2B-1-E | Serotonin 2b (5-HT2b) Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 34 | 0.36 | Binding ≤ 10μM |
5HT2C-1-E | Serotonin 2c (5-HT2c) Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 100 | 0.34 | Binding ≤ 10μM |
5HT6R-2-E | Serotonin 6 (5-HT6) Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2800 | 0.27 | Binding ≤ 10μM |
5HT7R-1-E | Serotonin 7 (5-HT7) Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1334 | 0.28 | Binding ≤ 10μM |
AA3R-3-E | Adenosine Receptor A3 (cluster #3 Of 6), Eukaryotic | Eukaryotes | 3 | 0.41 | Binding ≤ 10μM |
DRD4-3-E | Dopamine D4 Receptor (cluster #3 Of 4), Eukaryotic | Eukaryotes | 4 | 0.41 | Binding ≤ 10μM |
5HT2A-1-E | Serotonin 2a (5-HT2a) Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 32 | 0.36 | Functional ≤ 10μM |
DRD2-7-E | Dopamine D2 Receptor (cluster #7 Of 24), Eukaryotic | Eukaryotes | 491 | 0.30 | Binding ≤ 10μM |
Z104304-1-O | Adrenergic Receptor Alpha-1 (cluster #1 Of 3), Other | Other | 15 | 0.38 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 5012 | 0.26 | Functional ≤ 10μM |
Z50592-1-O | Oryctolagus Cuniculus (cluster #1 Of 8), Other | Other | 26 | 0.37 | Functional ≤ 10μM |
Z50597-1-O | Rattus Norvegicus (cluster #1 Of 12), Other | Other | 8 | 0.39 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AA3R_HUMAN | P33765 | Adenosine A3 Receptor, Human | 2.7 | 0.41 | Binding ≤ 1μM |
Z104304 | Z104304 | Adrenergic Receptor Alpha-1 | 15 | 0.38 | Binding ≤ 1μM |
DRD2_HUMAN | P14416 | Dopamine D2 Receptor, Human | 240 | 0.32 | Binding ≤ 1μM |
DRD2_RAT | P61169 | Dopamine D2 Receptor, Rat | 359 | 0.31 | Binding ≤ 1μM |
DRD4_HUMAN | P21917 | Dopamine D4 Receptor, Human | 3.5 | 0.41 | Binding ≤ 1μM |
5HT1D_HUMAN | P28221 | Serotonin 1d (5-HT1d) Receptor, Human | 260 | 0.32 | Binding ≤ 1μM |
5HT2A_RAT | P14842 | Serotonin 2a (5-HT2a) Receptor, Rat | 0.4 | 0.45 | Binding ≤ 1μM |
5HT2A_HUMAN | P28223 | Serotonin 2a (5-HT2a) Receptor, Human | 2.2 | 0.42 | Binding ≤ 1μM |
5HT2B_RAT | P30994 | Serotonin 2b (5-HT2b) Receptor, Rat | 0.4 | 0.45 | Binding ≤ 1μM |
5HT2C_RAT | P08909 | Serotonin 2c (5-HT2c) Receptor, Rat | 0.4 | 0.45 | Binding ≤ 1μM |
5HT2C_HUMAN | P28335 | Serotonin 2c (5-HT2c) Receptor, Human | 100 | 0.34 | Binding ≤ 1μM |
AA3R_HUMAN | P33765 | Adenosine A3 Receptor, Human | 2.7 | 0.41 | Binding ≤ 10μM |
Z104304 | Z104304 | Adrenergic Receptor Alpha-1 | 15 | 0.38 | Binding ≤ 10μM |
DRD2_RAT | P61169 | Dopamine D2 Receptor, Rat | 1800 | 0.28 | Binding ≤ 10μM |
DRD2_HUMAN | P14416 | Dopamine D2 Receptor, Human | 240 | 0.32 | Binding ≤ 10μM |
DRD4_HUMAN | P21917 | Dopamine D4 Receptor, Human | 3.5 | 0.41 | Binding ≤ 10μM |
5HT1A_RAT | P19327 | Serotonin 1a (5-HT1a) Receptor, Rat | 1817 | 0.28 | Binding ≤ 10μM |
5HT1B_HUMAN | P28222 | Serotonin 1b (5-HT1b) Receptor, Human | 6500 | 0.25 | Binding ≤ 10μM |
5HT1B_RAT | P28564 | Serotonin 1b (5-HT1b) Receptor, Rat | 1900 | 0.28 | Binding ≤ 10μM |
5HT1D_HUMAN | P28221 | Serotonin 1d (5-HT1d) Receptor, Human | 260 | 0.32 | Binding ≤ 10μM |
5HT2A_HUMAN | P28223 | Serotonin 2a (5-HT2a) Receptor, Human | 2.2 | 0.42 | Binding ≤ 10μM |
5HT2A_RAT | P14842 | Serotonin 2a (5-HT2a) Receptor, Rat | 0.4 | 0.45 | Binding ≤ 10μM |
5HT2B_RAT | P30994 | Serotonin 2b (5-HT2b) Receptor, Rat | 0.4 | 0.45 | Binding ≤ 10μM |
5HT2C_HUMAN | P28335 | Serotonin 2c (5-HT2c) Receptor, Human | 100 | 0.34 | Binding ≤ 10μM |
5HT2C_RAT | P08909 | Serotonin 2c (5-HT2c) Receptor, Rat | 0.4 | 0.45 | Binding ≤ 10μM |
5HT6R_HUMAN | P50406 | Serotonin 6 (5-HT6) Receptor, Human | 2800 | 0.27 | Binding ≤ 10μM |
5HT7R_HUMAN | P34969 | Serotonin 7 (5-HT7) Receptor, Human | 1334 | 0.28 | Binding ≤ 10μM |
Z50592 | Z50592 | Oryctolagus Cuniculus | 26 | 0.37 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 1995.26231 | 0.28 | Functional ≤ 10μM |
Z50597 | Z50597 | Rattus Norvegicus | 0.68 | 0.44 | Functional ≤ 10μM |
5HT2A_HUMAN | P28223 | Serotonin 2a (5-HT2a) Receptor, Human | 32 | 0.36 | Functional ≤ 10μM |
Description | Species |
---|---|
Adenosine P1 receptors | |
Dopamine receptors | |
G alpha (i) signalling events | |
G alpha (q) signalling events | |
G alpha (s) signalling events | |
Serotonin receptors |